Clover Health Investments (CLOV) Stock Price, News & Analysis

Company Overview

Clover Health Investments is a U.S. healthcare company focused on Medicare. Its insurance business offers Medicare Advantage plans to eligible beneficiaries in select markets, combining medical coverage with support intended to help members access care.

The company also developed the Clover Assistant, a technology platform that organizes patient information and provides clinicians with insights to support care decisions. Clover has described the platform as a way to help primary care providers identify health needs and coordinate care for people with complex conditions.

Founded in 2014, Clover Health became a publicly traded company in 2021 through a merger with a special purpose acquisition company. Andrew Toy serves as the company’s chief executive officer.

Key Stats

• Today's Range: $4.73 to $4.90
• 50-Day Range: $4.23 to $5.10
• 52-Week Range: $1.58 to $5.59
• Volume: 398,277 shs
• Average Volume: 5.79 million shs
• Market Capitalization: $2.47 billion
• P/E Ratio: 464.96
• Dividend Yield: N/A
• Price Target: $5.10
• Consensus Rating: Hold

Clover Health Investments Stock Analysis - MarketRank™

Clover Health Investments scored higher than 61% of companies evaluated by MarketBeat, and ranked 421st out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Hold

Consensus Rating

Clover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 3 buy ratings, 3 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Clover Health Investments is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Clover Health Investments has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 166.67%

Earnings Growth

Earnings for Clover Health Investments are expected to grow by 166.67% in the coming year, from $0.06 to $0.16 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Clover Health Investments is 488.49, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.68.

Price to Earnings Ratio vs. Sector

The P/E ratio of Clover Health Investments is 488.49, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.37.

Price to Book Value per Share Ratio

Clover Health Investments has a P/B Ratio of 6.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.67% of the float of Clover Health Investments has been sold short.

Short Interest Ratio / Days to Cover

Clover Health Investments has a short interest ratio ("days to cover") of 6.73.

Change versus previous month

Short interest in Clover Health Investments has recently decreased by 11.27%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Clover Health Investments does not currently pay a dividend.

Dividend Growth

Clover Health Investments does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.90

News Sentiment

Clover Health Investments has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Clover Health Investments this week, compared to 4 articles on an average week.

Search Interest

Only 4 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

4 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Clover Health Investments insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,462,479.00 in company stock.

Percentage Held by Insiders

23.51% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

19.77% of the stock of Clover Health Investments is held by institutions.

Company Calendar

• Last Earnings: 11/04/2026
• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Managed Healthcare
• Current Symbol: NASDAQ:CLOV
• CIK: 1801170
• Web: www.cloverhealth.com
• Phone: 201-432-2133
• Fax: N/A
• Employees: 724
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Clover Health Investments: $5.10
• High Price Target: $6.00
• Low Price Target: $2.50
• Potential Upside/Downside: +4.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.29
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.01
• Trailing P/E Ratio: 488.49
• Forward P/E Ratio: 30.50
• P/E Growth: N/A
• Net Income: -$85.55 million
• Net Margins: 0.45%
• Pretax Margin: 0.45%
• Return on Equity: 4.66%
• Return on Assets: 2.43%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.55
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: $1.92 billion
• Price / Sales: 1.35
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.74 per share
• Price / Book: 6.59

Miscellaneous

• Outstanding Shares: 531,160,000
• Free Float: 406,281,000
• Market Cap: $2.59 billion
• Optionable: Optionable
• Beta: 2.52